“You could have the cure for cancer, but if you can’t execute, it doesn’t matter.” ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Georgia Witchel's Mantis Biotech makes Parva, consumer software that reads how a person types and clicks to flag cognitive ...
Johnson & Johnson cut earnings guidance over biotech deals with Sail and Firefly. Here is why lower near-term profits might ...
The startups are part of a surge of young companies equipped with advanced drug prospects and quickly pivoting to the public ...
Whether it's looming tariff threats or the rise of China as a innovation powerhouse, you need a truly global view to navigate today's biopharma industry. | Whether it's looming tariff threats or the ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
Biotech is setting up as one of the more interesting risk-on trades heading into the back half of 2026. These three names are ...
Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.
In a sudden leadership shift, Legend Biotech announced that its CEO Ying Huang, Ph.D., resigned on Friday, with no permanent ...
Fortress Biotech transformed its balance sheet by selling a Priority Review Voucher for $205 million, netting $159 million.
A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results